Peripheral diabetic neuropathy (Q39536195)

12 September 2017

1 reference

title

Peripheral diabetic neuropathy (English)

1 reference

12 September 2017

Bays HE

1

1 reference

PubMed ID

3054362

12 September 2017

Pfeifer MA

series ordinal

2

1 reference

12 September 2017

1 November 1988

1 reference

Medical Clinics of North America

12 September 2017

1 reference

12 September 2017

72

1 reference

12 September 2017

6

1 reference

12 September 2017

1439-1464

1 reference

The natural history of acute painful neuropathy in diabetes mellitus

12 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930716-7

7 January 2021

Oculomotor palsy in diabetes mellitus: a clinico-pathological study

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930716-7

7 January 2021

Proximal diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930716-7

7 January 2021

Nerve biopsy and conduction studies in diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930716-7

7 January 2021

Continuous subcutaneous insulin infusion in the management of painful diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930716-7

7 January 2021

The prevalence of symptomatic, diabetic neuropathy in an insulin-treated population

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930716-7

7 January 2021

Diabetic peripheral neuropathy. Part I. Sensorimotor neuropathy (continuing education credit)

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930716-7

7 January 2021

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930716-7

1 reference

7 January 2021

Painful diabetic neuropathy. A morphometric study

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930716-7

7 January 2021

The biochemistry of the complications of diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930716-7

7 January 2021

A comparative study of peripheral nerve conduction in diabetes and non-diabetic chronic occlusive peripheral vascular disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930716-7

7 January 2021

Diabetic peripheral neuropathy. Part II. Autonomic neuropathies (continuing education credit)

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930716-7

7 January 2021

Effect of near normoglycaemia for two years on progression of early diabetic retinopathy, nephropathy, and neuropathy: the Oslo study

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930716-7

7 January 2021

Fiber loss is primary and multifocal in sural nerves in diabetic polyneuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930716-7

7 January 2021

Capillary number and percentage closed in human diabetic sural nerve

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930716-7

7 January 2021

The spatial distribution of fiber loss in diabetic polyneuropathy suggests ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930716-7

7 January 2021

Diabetic neuropathic cachexia

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930716-7

7 January 2021

Role of calcium and phosphoinositides in the actions of certain hormones and neurotransmitters

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930716-7

7 January 2021

Limited benefit of treatment of diabetic polyneuropathy with an aldose reductase inhibitor: a 24-week controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930716-7

7 January 2021

Effects of aldose reductase inhibitor treatment in diabetic polyneuropathy - a clinical and neurophysiological study.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930716-7

7 January 2021

Polyol pathway activity and myo-inositol metabolism. A suggested relationship in the pathogenesis of diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930716-7

7 January 2021

Mononeuropathy in Diabetes Mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930716-7

7 January 2021

Symptomatic treatment of peripheral diabetic neuropathy with carbamazepine (Tegretol�): Double blind crossover trial

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930716-7

7 January 2021

Sorbitol, inositol and nerve conduction in diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930716-7

7 January 2021

Nerve conduction abnormalities in untreated maturity-onset diabetes: relation to levels of fasting plasma glucose and glycosylated hemoglobin

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930716-7

7 January 2021

Glycemic control and nerve conduction abnormalities in non-insulin-dependent diabetic subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930716-7

7 January 2021

Nortriptyline and fluphenazine in the symptomatic treatment of diabetic neuropathy. A double-blind cross-over study

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930716-7

7 January 2021

Comparison of clinical couse and sequential electrophysiological tests in diabetics with symptomatic polyneuropathy and its implications for clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930716-7

7 January 2021

Action of Sorbinil in Diabetic Peripheral Nerve: Relationship of Polyol (Sorbitol) Pathway Inhibition to a myo-Inositol-mediated Defect in Sodium-Potassium ATPase Activity

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930716-7

7 January 2021

Sodium- and energy-dependent uptake of myo-inositol by rabbit peripheral nerve. Competitive inhibition by glucose and lack of an insulin effect

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930716-7

7 January 2021

Glucose-induced alterations in nerve metabolism: current perspective on the pathogenesis of diabetic neuropathy and future directions for research and therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930716-7

7 January 2021

Effects of acute experimental diabetes on composite energy metabolism in peripheral nerve axons and Schwann cells

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930716-7

7 January 2021

Diabetic neuropathy: Influence of age, sex, metabolic control, and duration of diabetes on motor conduction velocity

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930716-7

7 January 2021

Variations in motor conduction velocity produced by acute changes of the metabolic state in diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930716-7

7 January 2021

Clinical trial of an aldose reductase inhibitor in diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930716-7

7 January 2021

Pathophysiology in diabetic autonomic neuropathy: cardiovascular, hormonal, and metabolic studies

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930716-7

7 January 2021

Diabetic polyradiculopathy simulating lumbar disc disease. Report of four cases

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930716-7

7 January 2021

Prevention of deterioration of renal and sensory-nerve function by more intensive management of insulin-dependent diabetic patients. A two-year randomised prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930716-7

7 January 2021

Treatment of severely painful diabetic neuropathy with an aldose reductase inhibitor: relief of pain and improved somatic and autonomic nerve function

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930716-7

7 January 2021

Aldose reductase inhibition improves nerve conduction velocity in diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930716-7

7 January 2021

Subnormal pancreatic polypeptide and epinephrine responses to insulin-induced hypoglycemia identify patients with insulin-dependent diabetes mellitus predisposed to develop overt autonomic neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930716-7

7 January 2021

Thoracic root pain in diabetes: the spectrum of clinical and electromyographic findings

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930716-7

7 January 2021

Distal slowing of motor nerve conduction velocity in diabetic polyneuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930716-7

7 January 2021

Bell's palsy and diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930716-7

7 January 2021

Effects of continuous subcutaneous insulin infusion and intensified conventional therapy on peripheral and autonomic nerve dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930716-7

7 January 2021

Abdominal pain caused by diabetic radiculopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930716-7

7 January 2021

Prevention of some electrophysiologic and biochemical abnormalities with oxygen supplementation in experimental diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930716-7

7 January 2021

Recent advances in the pathogenesis of diabetic neuropathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930716-7

7 January 2021

Six-month treatment with sorbinil in asymptomatic diabetic neuropathy. Failure to improve abnormal nerve function

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930716-7

7 January 2021

Mechanism of pain in diabetic peripheral neuropathy. Effect of glucose on pain perception in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930716-7

7 January 2021

Diabetic autonomic neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930716-7

7 January 2021

Increased endoneurial albumin in diabetic polyneuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930716-7

7 January 2021

Correlations among autonomic, sensory, and motor neural function tests in untreated non-insulin-dependent diabetic individuals.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930716-7

7 January 2021

Autonomic neural dysfunction in recently diagnosed diabetic subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930716-7

7 January 2021

Changes in nerve conduction velocity after six weeks of glucoregulation with portable insulin infusion pumps

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930716-7

7 January 2021

Aldose reductase inhibitors in clinical practice. Preliminary studies on diabetic neuropathy and retinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930716-7

7 January 2021

Axonopathy and microangiopathy in chronic alloxan diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930716-7

7 January 2021

Ischemic mononeuropathy multiplex associated with diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930716-7

7 January 2021

A note on the mechanism of resistance to anoxia and ischaemia in pathophysiological mammalian myelinated nerve

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930716-7

7 January 2021

Phenytoin in the treatment of diabetic symmetrical polyneuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930716-7

7 January 2021

Reversibility and preventability of the decrease in slow axonal transport velocity in experimental diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930716-7

7 January 2021

The axonopathy of diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930716-7

7 January 2021

Significance of Tissue myo -Inositol Concentrations in Metabolic Regulation in Nerve

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930716-7

7 January 2021

Body stature as a risk factor for diabetic sensory neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930716-7

7 January 2021

Diabetic thoracoabdominal neuropathy: clinical and electrodiagnostic features

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930716-7

7 January 2021

Small vessel disease in progressive diabetic neuropathy associated with good metabolic control

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930716-7

7 January 2021

Endoneurial blood flow and oxygen tension in the sciatic nerves of rats with experimental diabetic neuropathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930716-7

7 January 2021

Depression masquerading as diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930716-7

7 January 2021

Nonenzymatic glycosylation of peripheral nerve protein in diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930716-7

7 January 2021

Diabetic truncal polyneuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930716-7

7 January 2021

Pathology of oculomotor nerve palsy in diabetics

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930716-7

7 January 2021

Structural and functional consequences of increased tubulin glycosylation in diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930716-7

7 January 2021

Microvascular Disease in Diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930716-7

7 January 2021

Pain relief in diabetic neuropathy: the effectiveness of imipramine and related drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930716-7

7 January 2021

A Controlled Trial of Sorbinil, an Aldose Reductase Inhibitor, in Chronic Painful Diabetic Neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930716-7

7 January 2021

Chronic and remitting painful diabetic polyneuropathy. Correlations with clinical features and subsequent changes in neurophysiology

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930716-7

7 January 2021

Nerve function and metabolic control in teenage diabetics

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930716-7

7 January 2021

Variable relationship between peripheral somatic and autonomic neuropathy in patients with different syndromes of diabetic polyneuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930716-7

7 January 2021

Ophthalmoplegia in Diabetes Mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930716-7

7 January 2021

10.1016/S0025-7125(16)30716-7

Identifiers

DOI

0 references

PubMed ID

3054362

1 reference

PubMed ID

3054362